Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 971-973, August 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolasny, B. L.
Right arrow Articles by Prohaska, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolasny, B. L.
Right arrow Articles by Prohaska, J. V.

The Effects of Triamcinolone Diacetate on Levels of 3-Methylcholanthrene in Rat Mammary Glands*

Bruce L. Bolasny, Sherwyn E. Warren and John V. Prohaska

( Department of Surgery, The University of Chicago School of Medicine, Chicago, Illinois)

The suppression of 3-methylcholanthrene (3-MC)-induced mammary carcinoma in the white rat produced by triamcinolone diacetate was investigated by the quantitative analysis of the localization of 3-MC in the mammary gland of rats receiving triamcinolone diacetate as compared with rats not receiving this steroid. The analysis shows that there is no difference in the uptake of 3-MC in rats receiving triamcinolone diacetate. Levels of 3-MC in the mammary gland increase in direct proportion to the quantity of carcinogen fed. A single oral dose (50 mg.) disappears from the breast in 15 days in normal as well as in triamcinolone-treated rats. The results indicate that the suppression of mammary carcinoma produced by triamcinolone diacetate cannot be explained by the altered uptake or clearance of carcinogen by the mammary gland.

* This work was supported by grants from the Gladys Bowyer Foundation and Mr. Burr L. Robbins.

Received 11/12/62.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
T. Ohnishi, K. Fukamachi, Y. Ohshima, X. Jiegou, S. Ueda, M. Iigo, N. Takasuka, A. Naito, K.-i. Fujita, Y. Matsuoka, et al.
Possible Application of Human c-Ha-ras Proto-Oncogene Transgenic Rats in a Medium-Term Bioassay Model for Carcinogens
Toxicol Pathol, April 1, 2007; 35(3): 436 - 443.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.